Literature DB >> 28514619

Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis.

Ratko Djukanovic1, Paul M O'Byrne1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28514619     DOI: 10.1056/NEJMe1704402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis.

Authors:  Jonathan Steinfeld; Eric S Bradford; Judith Brown; Stephen Mallett; Steven W Yancey; Praveen Akuthota; Maria C Cid; Gerald J Gleich; David Jayne; Paneez Khoury; Carol A Langford; Peter A Merkel; Frank Moosig; Ulrich Specks; Peter F Weller; Michael E Wechsler
Journal:  J Allergy Clin Immunol       Date:  2018-12-19       Impact factor: 10.793

Review 2.  Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma.

Authors:  Florence Roufosse
Journal:  Front Med (Lausanne)       Date:  2018-04-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.